First Alzheimer’s drug will be unavailable through the NHS
The UK’s health regulator, Nice, has rejected a drug that can slow the progression of Alzheimer’s, claiming the benefits are too small to justify the cost.
Examining how fast cognitive decline can happen with early Alzheimer’s
When people’s loved ones are diagnosed with the disease, they ask questions about what to expect. We examine new research that looks into cognitive decline and how the new drugs approved for Alzheimer’s could help.
